Suppr超能文献

相似文献

3
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
N Engl J Med. 2000 Dec 7;343(23):1688-96. doi: 10.1056/NEJM200012073432304.
5
Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca, and activate NFAT and Akt signaling.
Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H306-H319. doi: 10.1152/ajpheart.00272.2020. Epub 2020 Jul 3.
6
Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
Circ Cardiovasc Genet. 2012 Oct 1;5(5):503-10. doi: 10.1161/CIRCGENETICS.112.962761. Epub 2012 Sep 4.
7
A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
Biochim Biophys Acta. 2013 Apr;1833(4):833-9. doi: 10.1016/j.bbamcr.2012.11.003. Epub 2012 Nov 9.
8
[Mutations in genes for sarcomeric proteins].
Nihon Rinsho. 2000 Jan;58(1):117-22.
9
The structural basis of alpha-tropomyosin linked (Asp230Asn) familial dilated cardiomyopathy.
J Mol Cell Cardiol. 2017 Jul;108:127-137. doi: 10.1016/j.yjmcc.2017.06.001. Epub 2017 Jun 7.

引用本文的文献

2
Dilated Cardiomyopathy: A Genetic Journey from Past to Future.
Int J Mol Sci. 2024 Oct 25;25(21):11460. doi: 10.3390/ijms252111460.
3
In silico and in vitro models reveal the molecular mechanisms of hypocontractility caused by M8R.
Front Physiol. 2024 Aug 30;15:1452509. doi: 10.3389/fphys.2024.1452509. eCollection 2024.
7
Sex Differences in Heart Failure: What Do We Know?
J Cardiovasc Dev Dis. 2023 Jun 29;10(7):277. doi: 10.3390/jcdd10070277.
8
Cardiovascular Magnetic Resonance Imaging in Familial Dilated Cardiomyopathy.
Medicina (Kaunas). 2023 Feb 23;59(3):439. doi: 10.3390/medicina59030439.
9
Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.
J Am Coll Cardiol. 2022 Nov 22;80(21):1981-1994. doi: 10.1016/j.jacc.2022.08.804.

本文引用的文献

1
Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline.
J Card Fail. 2009 Mar;15(2):83-97. doi: 10.1016/j.cardfail.2009.01.006.
2
Long-term outcome and risk stratification in dilated cardiolaminopathies.
J Am Coll Cardiol. 2008 Oct 7;52(15):1250-60. doi: 10.1016/j.jacc.2008.06.044.
6
Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.
Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H284-91. doi: 10.1152/ajpheart.00128.2007. Epub 2007 Mar 9.
7
Incidence, causes, and outcomes of dilated cardiomyopathy in children.
JAMA. 2006 Oct 18;296(15):1867-76. doi: 10.1001/jama.296.15.1867.
8
A contemporary approach to hypertrophic cardiomyopathy.
Circulation. 2006 Jun 20;113(24):e858-62. doi: 10.1161/CIRCULATIONAHA.105.591982.
10
Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease.
Ann Intern Med. 2005 Jul 19;143(2):108-15. doi: 10.7326/0003-4819-143-2-200507190-00009.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验